Programmable Antivirals and Just-in-Time Vaccines: Biosecurity Implications of Viral RNA Secondary Structure Targeting.

Health SecurityVol. 21, No. 1 CommentaryProgrammable Antivirals and Just-in-Time Vaccines: Biosecurity Implications of Viral RNA Secondary Structure TargetingJaspreet Pannu and Jeffrey S. GlennJaspreet PannuAddress correspondence to: Jaspreet Pannu, MD, 300 Pasteur Drive, Stanford, CA 94305 E-mail Address: jassi@jhu.eduJaspreet Pannu, MD, is a Resident Physician, Department of Medicine, Stanford University School of Medicine, Stanford, CA; and a Fellow, Center for Health Security, Johns Hopkins School of Public Health, Baltimore, MD.Search for more papers by this author and Jeffrey S. GlennJeffrey S. Glenn, MD, PhD, is the Joseph D. Grant Professor, Department of Medicine, and Professor, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA; and Director, ViRx@Stanford, Stanford Medicine, Stanford, CA. He is also a Physician, Veterans Administration Medical Center, Palo Alto, CA.Search for more papers by this authorPublished Online:7 Feb 2023https://doi.org/10.1089/hs.2022.0098AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 21Issue 1Feb 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Jaspreet Pannu and Jeffrey S. Glenn.Programmable Antivirals and Just-in-Time Vaccines: Biosecurity Implications of Viral RNA Secondary Structure Targeting.Health Security.Feb 2023.81-84.http://doi.org/10.1089/hs.2022.0098Published in Volume: 21 Issue 1: February 7, 2023Online Ahead of Print:December 19, 2022KeywordsCOVID-19Medical countermeasuresVaccinesPandemic influenzaPDF download